Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- High Debt Company with a Debt to Equity ratio (avg) at times
2
The company has declared Negative results for the last 10 consecutive quarters
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Software Products
SEK 47 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-2.75
101.67%
-2.92
Revenue and Profits:
Net Sales:
20 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.02%
0%
7.02%
6 Months
-18.39%
0%
-18.39%
1 Year
-25.84%
0%
-25.84%
2 Years
-66.94%
0%
-66.94%
3 Years
-77.07%
0%
-77.07%
4 Years
-76.03%
0%
-76.03%
5 Years
-75.55%
0%
-75.55%
Ortivus AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.24%
EBIT Growth (5y)
-239.06%
EBIT to Interest (avg)
0.68
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-3.72
Sales to Capital Employed (avg)
2.92
Tax Ratio
0.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
58.09%
ROE (avg)
19.34%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-3.32
EV to EBIT
-17.05
EV to EBITDA
98.34
EV to Capital Employed
3.47
EV to Sales
1.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.37%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
19.70
18.10
8.84%
Operating Profit (PBDIT) excl Other Income
0.50
-1.10
145.45%
Interest
1.20
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.50
-2.40
-170.83%
Operating Profit Margin (Excl OI)
-6.90%
-131.00%
12.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 8.84% vs -15.02% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -170.83% vs 75.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
80.40
84.10
-4.40%
Operating Profit (PBDIT) excl Other Income
-7.90
-13.30
40.60%
Interest
5.30
0.60
783.33%
Exceptional Items
-8.50
0.00
Consolidate Net Profit
-24.50
-18.20
-34.62%
Operating Profit Margin (Excl OI)
-131.50%
-195.00%
6.35%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -4.40% vs -19.52% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -34.62% vs -408.47% in Dec 2023
About Ortivus AB 
Ortivus AB
Software Products
Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
Company Coordinates 
Company Details
Svardvagen 19 , DANDERYD None : 182 33
Registrar Details






